...
首页> 外文期刊>EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology >Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach
【24h】

Clinical outcomes after intravascular ultrasound and fractional flow reserve assessment of intermediate coronary lesions. Propensity score matching of large cohorts from two institutions with a differential approach

机译:血管内超声检查和中间冠状动脉病变的部分血流储备评估后的临床结局。来自两个机构的大型队列的倾向得分匹配,采用差分方法

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Aims: Assessment of intermediate coronary lesions can be done with fractional flow reserve (FFR) and intravascular ultrasound (IVUS). There are no randomised trials and only a small registry from one centre is available but this is subject to important bias. We sought to evaluate the clinical outcomes of an FFR strategy compared with an IVUS strategy for intermediate lesion assessment. Methods and results: We compared the outcome of patients assessed with FFR and IVUS in two centres with a differential approach. After propensity score matching 400 pairs of patients were included. Revascularisation was done when FFR was 0.75 or minimum lumen area was 4 mm2 in vessels 3 mm, and 3.5 mm2 in vessels 2.5-3 mm, along with plaque burden 50%. After FFR and IVUS, 72% and 51.2% of lesions, respectively, were left untreated (p0.001). At one and two years no significant differences in MACE-free survival were observed in overall groups (97.7% at one year and 93.1% at two years in the FFR group and 97.7% at one year and 95.6% at two years in the IVUS group; p=0.35) and among those with deferred intervention (97.9% at one year and 94.2% at two years in the FFR group and 96.5% at one year and 93.6% at two years in the IVUS group; p=0.7). Conclusions: IVUS and FFR may be safely used to defer revascularisation of intermediate lesions. IVUS induces a higher degree of revascularisation but much lower than previously reported and does not affect the clinical outcome.
机译:目的:可以通过分数流量储备(FFR)和血管内超声(IVUS)评估中间冠状动脉病变。没有随机试验,只有一个中心的一个小型注册中心存在,但是这有很大的偏差。我们试图评估FFR策略与IVUS策略进行中期病变评估的临床结果。方法和结果:我们比较了两个中心采用FFR和IVUS评估的患者的结局,采用的是差异方法。在倾向得分匹配之后,包括400对患者。当FFR <0.75或最小内腔面积<3 mm2的血管和<3.5 mm2 2.5-3 mm的血管,以及斑块负荷> 50%时,进行血运重建。 FFR和IVUS后,分别有72%和51.2%的病变未得到治疗(p <0.001)。在第1年和第2年,总体组无MACE生存率无显着差异(FFR组为1年为97.7%,两年为93.1%,IVUS组为一年为97.7%和两年为95.6%。 ; p = 0.35)和延期干预者(FFR组一年为97.9%,两年为94.2%,IVUS组一年为96.5%,两年为93.6%; p = 0.7)。结论:IVUS和FFR可以安全地用于延迟中间病变的血运重建。 IVUS引起更高程度的血运重建,但比以前报道的要低得多,并且不影响临床结果。

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号